Clinical Trials
5 trialsNCT05532722 2026-05-06
ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Abcuro, Inc.
Phase 1/2 Completed
NCT05475925 2026-04-17
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Dren Bio
Phase 1/2 Recruiting
NCT00002663 2023-02-13
Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Atara Biotherapeutics
Phase 1/2 Completed
NCT03239392 2021-05-25
A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
Bioniz Therapeutics
Phase 1/2 Completed
NCT02742727 2016-12-06
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1/2 Unknown